ORPP logo
Image from Google Jackets

Cellular Senescence : Implications for Cancer Therapy.

By: Contributor(s): Material type: TextTextSeries: Cancer Etiology, Diagnosis and Treatments SeriesPublisher: Hauppauge : Nova Science Publishers, Incorporated, 2008Copyright date: ©2009Edition: 1st edDescription: 1 online resource (123 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781617281730
Subject(s): Genre/Form: Additional physical formats: Print version:: Cellular SenescenceLOC classification:
  • QH608.M57 2009
Online resources:
Contents:
Intro -- CELLULAR SENESCENCE: IMPLICATIONS FOR CANCER THERAPY -- CELLULAR SENESCENCE: IMPLICATIONS FOR CANCER THERAPY -- CONTENTS -- PREFACE -- Chapter 1 INTRODUCTION -- Chapter 2 TELOMERASE-BASED SENESCENCE -- Chapter 3 STRESS-TRIGGERED PREMATURE SENESCENCE -- Chapter 4 FEATURES OF PREMATURE SENESCENCE -- CELL MORPHOLOGY -- SENESCENCE-ASSOCIATED β-GALACTOSIDASE EXPRESSION -- SUSTAINED P21 UP-REGULATION -- INHIBITION OF CELL GROWTH -- NUCLEAR ACCUMULATION OF ACTIN -- STRESS-ASSOCIATED NUCLEAR FOCI -- Chapter 5 DIFFERENT MODES OF GROWTH ARREST ARE TRIGGERED BY GENOTOXIC STRESS -- Chapter 6 CLASSIFICATION OF CDK INHIBITORS -- Chapter 7 ROLES OF P21, P53 AND P16 IN SENESCENCE -- Chapter 8 REGULATION OF P21WAF1 TRANSCRIPT AND P21 PROTEIN LEVELS -- Chapter 9 MODE OF ACTION OF P21 -- Chapter 10 P53 SIGNALING AND CELLULAR RESPONSE TO DNA-DAMAGING AGENTS -- IONIZING RADIATION-TRIGGERED RESPONSES -- UV-TRIGGERED RESPONSES -- APOPTOTIC THRESHOLD IN CANCER CELLS EXPOSED TO DNA-DAMAGING AGENTS -- WHAT FACTORS MIGHT CONTRIBUTE TO THE APOPTOTIC THRESHOLD? -- Chapter 11 CELL-TO-CELL COMMUNICATION TRIGGERED BY DNA-DAMAGING AGENTS -- ROS-ASSOCIATED BYSTANDER EFFECT OF RADIATION -- P53-MEDIATED BYSTANDER EFFECT OF RADIATION -- DIFFUSIBLE "AT-CORRECTING" FACTORS -- Chapter 12 MODULATING SENESCENCE IN THE CONTEXT OF CANCER THERAPY -- PROS AND CONS OF ACTIVATING SENESCENCE IN CANCER CELLS -- ASSAYS FOR PRECLINICAL TESTING OF ANTICANCER AGENTS -- Chapter 13 AGING, SENESCENCE, AND "HORMESIS" -- Chapter 14 HUMAN GENETIC DISORDERS ASSOCIATED WITH GENOMIC INSTABILITY AND CANCER PREDISPOSITION -- WERNER SYNDROME -- HUTCHINSON-GILFORD'S PROGERIA SYNDROME -- BLOOM SYNDROME -- ROTHMUND-THOMPSON SYNDROME -- COCKAYNE SYNDROME -- XERODERMA PIGMENTOSUM -- FANCONI ANEMIA -- ATAXIA TELANGIECTASIA -- LI-FRAUMENI SYNDROME.
Chapter 15 BIOLOGICAL CONSEQUENCES OF THE FAILURE OF CELLS TO UNDERGO SENESCENCE/APOPTOSIS FOLLOWING GENOTOXIC STRESS: BASIS FOR THE EMERGENCE OF HIGHLY METASTATIC AND THERAPY-RESISTANT DISEASE? -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- INDEX -- Blank Page.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- CELLULAR SENESCENCE: IMPLICATIONS FOR CANCER THERAPY -- CELLULAR SENESCENCE: IMPLICATIONS FOR CANCER THERAPY -- CONTENTS -- PREFACE -- Chapter 1 INTRODUCTION -- Chapter 2 TELOMERASE-BASED SENESCENCE -- Chapter 3 STRESS-TRIGGERED PREMATURE SENESCENCE -- Chapter 4 FEATURES OF PREMATURE SENESCENCE -- CELL MORPHOLOGY -- SENESCENCE-ASSOCIATED β-GALACTOSIDASE EXPRESSION -- SUSTAINED P21 UP-REGULATION -- INHIBITION OF CELL GROWTH -- NUCLEAR ACCUMULATION OF ACTIN -- STRESS-ASSOCIATED NUCLEAR FOCI -- Chapter 5 DIFFERENT MODES OF GROWTH ARREST ARE TRIGGERED BY GENOTOXIC STRESS -- Chapter 6 CLASSIFICATION OF CDK INHIBITORS -- Chapter 7 ROLES OF P21, P53 AND P16 IN SENESCENCE -- Chapter 8 REGULATION OF P21WAF1 TRANSCRIPT AND P21 PROTEIN LEVELS -- Chapter 9 MODE OF ACTION OF P21 -- Chapter 10 P53 SIGNALING AND CELLULAR RESPONSE TO DNA-DAMAGING AGENTS -- IONIZING RADIATION-TRIGGERED RESPONSES -- UV-TRIGGERED RESPONSES -- APOPTOTIC THRESHOLD IN CANCER CELLS EXPOSED TO DNA-DAMAGING AGENTS -- WHAT FACTORS MIGHT CONTRIBUTE TO THE APOPTOTIC THRESHOLD? -- Chapter 11 CELL-TO-CELL COMMUNICATION TRIGGERED BY DNA-DAMAGING AGENTS -- ROS-ASSOCIATED BYSTANDER EFFECT OF RADIATION -- P53-MEDIATED BYSTANDER EFFECT OF RADIATION -- DIFFUSIBLE "AT-CORRECTING" FACTORS -- Chapter 12 MODULATING SENESCENCE IN THE CONTEXT OF CANCER THERAPY -- PROS AND CONS OF ACTIVATING SENESCENCE IN CANCER CELLS -- ASSAYS FOR PRECLINICAL TESTING OF ANTICANCER AGENTS -- Chapter 13 AGING, SENESCENCE, AND "HORMESIS" -- Chapter 14 HUMAN GENETIC DISORDERS ASSOCIATED WITH GENOMIC INSTABILITY AND CANCER PREDISPOSITION -- WERNER SYNDROME -- HUTCHINSON-GILFORD'S PROGERIA SYNDROME -- BLOOM SYNDROME -- ROTHMUND-THOMPSON SYNDROME -- COCKAYNE SYNDROME -- XERODERMA PIGMENTOSUM -- FANCONI ANEMIA -- ATAXIA TELANGIECTASIA -- LI-FRAUMENI SYNDROME.

Chapter 15 BIOLOGICAL CONSEQUENCES OF THE FAILURE OF CELLS TO UNDERGO SENESCENCE/APOPTOSIS FOLLOWING GENOTOXIC STRESS: BASIS FOR THE EMERGENCE OF HIGHLY METASTATIC AND THERAPY-RESISTANT DISEASE? -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- INDEX -- Blank Page.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.